Free tool
Healthcare stocks
We cover 238 companies in the Healthcare sector. The median market value in the group is $3.98B. Across the group, the median move over the past trading day is −0.15%. 78% of the 230 with a 200-day average trade above it. Price change over the past year runs from −17.7% to +226.6% across the middle 80 percent of the group, with a median of +37.2%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
238 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% | Oct 29, 2026 |
| LLY | Eli Lilly and Company | $1,189.41 | −2.56% | +10.47% | +62.80% | Oct 29, 2026 |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% | Oct 13, 2026 |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% | Oct 29, 2026 |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% | Oct 29, 2026 |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% | Oct 29, 2026 |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% | Oct 27, 2026 |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% | Oct 27, 2026 |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% | Oct 30, 2026 |
| AZN | AstraZeneca PLC | $166.27 | −3.60% | −8.27% | +5.09% | Oct 30, 2026 |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% | Oct 30, 2026 |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% | Nov 3, 2026 |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% | Oct 21, 2026 |
| NVO.WA | Novo Nordisk A/S | 175.12 PLN | −10.34% | −1.45% | −9.22% | Nov 4, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% | Nov 4, 2026 |
| NVO | Novo Nordisk A/S | $47.19 | −7.40% | −6.62% | −13.32% | Nov 4, 2026 |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% | Oct 14, 2026 |
| PODD | Insulet Corporation | $143.38 | −14.38% | −49.32% | −57.12% | Nov 5, 2026 |
| AVTR | Avantor, Inc. | $14.50 | +16.75% | +26.53% | +9.93% | Oct 28, 2026 |
| PTGX | Protagonist Therapeutics, Inc. | $151.50 | +10.71% | +73.78% | +146.62% | Nov 5, 2026 |
| OSCR | Oscar Health, Inc. | $31.24 | −0.51% | +108.68% | +83.55% | Nov 9, 2026 |
| TWST | Twist Bioscience Corporation | $150.06 | +69.46% | +363.29% | +451.89% | Nov 16, 2026 |
| KRK.WA | Krka, d. d. | 1,110.00 PLN | −2.63% | +29.07% | +30.59% | Nov 12, 2026 |
| PCVX | Vaxcyte, Inc. | $61.09 | +11.89% | +31.49% | +99.97% | Nov 3, 2026 |
| IMVT | Immunovant, Inc. | $43.89 | +12.83% | +69.39% | +189.13% | Nov 9, 2026 |
| QGEN | Qiagen N.V. | $43.36 | +2.55% | −4.05% | −9.65% | Nov 4, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% | Nov 5, 2026 |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% | Nov 4, 2026 |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% | Aug 27, 2026 |
| BRKR | Bruker Corporation | $57.06 | −9.30% | +18.78% | +70.56% | Nov 3, 2026 |
| ATR | AptarGroup, Inc. | $135.24 | −1.52% | +11.23% | −1.89% | Oct 29, 2026 |
| 4151.T | Kyowa Kirin Co., Ltd. | 2,613.00 JPY | −3.33% | +3.94% | +4.01% | Nov 2, 2026 |
| 4523.T | Eisai Co., Ltd. | 4,792.00 JPY | −6.22% | +1.75% | +7.64% | Nov 10, 2026 |
| TGTX | TG Therapeutics, Inc. Common Stock | $55.03 | +0.29% | +87.94% | +92.61% | Nov 2, 2026 |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% | Nov 5, 2026 |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% | Aug 27, 2026 |
| ALKS | Alkermes plc | $49.16 | −2.65% | +73.96% | +68.07% | Oct 28, 2026 |
| SYRE | Spyre Therapeutics, Inc. | $93.61 | −6.36% | +206.10% | +446.12% | Nov 3, 2026 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $111.87 | +3.54% | +6.53% | +9.35% | Nov 3, 2026 |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% | Nov 4, 2026 |
| 2413.T | M3, Inc. | 1,796.00 JPY | −9.48% | −12.15% | −17.22% | Nov 11, 2026 |
| 4528.T | Ono Pharmaceutical Co., Ltd. | 2,462.50 JPY | −1.16% | +14.31% | +54.43% | Oct 29, 2026 |
| SRRK | Scholar Rock Holding Corporation | $60.04 | +21.61% | +40.28% | +74.18% | Nov 12, 2026 |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% | Nov 4, 2026 |
| ALK-B.CO | ALK-Abelló A/S | 208.80 DKK | −6.62% | −7.16% | +5.09% | Nov 17, 2026 |
| HNGE | Hinge Health, Inc. | $90.50 | +20.27% | +98.64% | +56.66% | Nov 3, 2026 |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% | Oct 27, 2026 |
| PACS | PACS Group, Inc. | $44.39 | −5.47% | +12.35% | +274.28% | Nov 9, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| HIMS | Hims & Hers Health, Inc. | $29.83 | +1.74% | −10.72% | −32.22% | Nov 9, 2026 |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% | Nov 9, 2026 |
| 3391.T | Tsuruha Holdings Inc. | 2,379.00 JPY | −8.08% | −16.55% | +5.97% | Oct 9, 2026 |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | 387,000.00 KRW | +9.79% | −45.87% | +15.35% | Oct 23, 2026 |
| ERAS | Erasca, Inc. | $19.15 | +5.45% | +433.43% | +1112.03% | Nov 11, 2026 |
| 7747.T | Asahi Intecc Co., Ltd. | 3,876.00 JPY | +4.76% | +30.59% | +53.99% | Nov 13, 2026 |
| LNTH | Lantheus Holdings, Inc. | $100.82 | −1.77% | +49.87% | +77.38% | Nov 5, 2026 |
| ORKA | Oruka Therapeutics, Inc. | $99.44 | +9.94% | +251.75% | +555.07% | Nov 11, 2026 |
| RADL3.SA | Raia Drogasil S.A. | 19.31 BRL | +6.10% | −18.17% | +7.42% | Nov 3, 2026 |
| HLUN-B.CO | H. Lundbeck A/S | 42.68 DKK | +1.19% | +2.35% | +8.99% | Nov 11, 2026 |
| 3088.T | MatsukiyoCocokara & Co. | 2,575.00 JPY | −4.35% | −4.12% | −14.74% | Nov 12, 2026 |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% | Nov 11, 2026 |
| COGT | Cogent Biosciences, Inc. | $36.72 | −9.71% | +5.70% | +196.85% | Nov 3, 2026 |
| BLTE | Belite Bio, Inc | $156.69 | +0.47% | −1.62% | +144.07% | Nov 9, 2026 |
| LQDA | Liquidia Corporation | $71.36 | −17.81% | +127.26% | +154.86% | Nov 3, 2026 |
| AMRX | Amneal Pharmaceuticals, Inc. | $17.99 | −4.10% | +42.10% | +92.20% | Oct 29, 2026 |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% | Oct 29, 2026 |
| XENE | Xenon Pharmaceuticals Inc. | $63.79 | −1.77% | +43.38% | +64.11% | Nov 2, 2026 |
| BLCO.TO | Bausch + Lomb Corporation | 24.00 CAD | +2.61% | +5.31% | +19.34% | Oct 28, 2026 |
| BLCO | Bausch + Lomb Corporation | $17.25 | +3.85% | +4.04% | +18.56% | Oct 28, 2026 |
| DNTH | Dianthus Therapeutics, Inc. | $110.76 | +9.01% | +179.13% | +356.93% | Nov 5, 2026 |
| STVN | Stevanato Group S.p.A. | $22.38 | +11.07% | +8.75% | −0.09% | Nov 5, 2026 |
| PTCT | PTC Therapeutics, Inc. Common Stock | $72.69 | −3.58% | −5.28% | +46.02% | Nov 5, 2026 |
| KNSA | Kiniksa Pharmaceuticals International, plc | $78.68 | −0.96% | +87.31% | +133.47% | Oct 27, 2026 |
| RDNT | RadNet, Inc. | $76.47 | +20.96% | +7.78% | +7.27% | Nov 5, 2026 |
| MIRM | Mirum Pharmaceuticals, Inc. | $98.51 | −12.22% | +26.18% | +31.96% | Nov 4, 2026 |
| DFTX | Definium Therapeutics, Inc. | $43.77 | +4.31% | +220.89% | +344.37% | Nov 5, 2026 |
| TFX | Teleflex Incorporated | $138.74 | +3.38% | +13.97% | +8.06% | Oct 29, 2026 |
| LGND | Ligand Pharmaceuticals Incorporated | $287.85 | −2.85% | +51.41% | +80.92% | Nov 5, 2026 |
| CRSP | CRISPR Therapeutics AG | $59.23 | +24.56% | +10.15% | +10.65% | Nov 9, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| SHC | Sotera Health Company | $19.54 | +10.02% | +10.46% | +18.42% | Nov 3, 2026 |
| MMED | MiniMed Group, Inc. | $19.49 | +10.49% | +5.41% | +5.41% | Sep 1, 2026 |
| MMSI | Merit Medical Systems, Inc. | $90.54 | +15.65% | +4.73% | −0.28% | Oct 29, 2026 |
| ACAD | ACADIA Pharmaceuticals Inc. | $29.58 | +13.73% | +12.51% | +11.33% | Nov 4, 2026 |
| DYN | Dyne Therapeutics, Inc. | $26.36 | +1.78% | +42.49% | +93.26% | Nov 5, 2026 |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | 88,400.00 KRW | +16.93% | −28.07% | −11.24% | Nov 5, 2026 |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% | Nov 5, 2026 |
| EWTX | Edgewise Therapeutics, Inc. | $44.38 | +9.99% | +86.86% | +207.13% | Nov 5, 2026 |
| LFST | LifeStance Health Group, Inc. | $12.15 | +8.10% | +74.57% | +121.31% | Nov 5, 2026 |
| CELC | Celcuity Inc. | $95.08 | +15.30% | −5.44% | +90.31% | Nov 11, 2026 |
| WAY | Waystar Holding Corp. | $24.17 | +2.03% | −22.95% | −34.97% | Oct 28, 2026 |
| 128940.KS | Hanmi Pharm. Co., Ltd. | 503,000.00 KRW | +56.21% | +13.96% | +66.34% | Oct 29, 2026 |
| BLLN | BillionToOne, Inc. | $96.22 | −28.00% | +7.76% | −11.68% | Nov 5, 2026 |
| ICUI | ICU Medical, Inc. | $179.59 | +8.33% | +29.64% | +41.83% | Nov 5, 2026 |
| NVST | Envista Holdings Corporation | $27.80 | +3.12% | +28.17% | +30.89% | Oct 28, 2026 |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% | Nov 11, 2026 |
| CON | Concentra Group Holdings Parent, Inc. | $34.95 | +6.91% | +81.01% | +50.93% | Nov 5, 2026 |
| DOCS | Doximity, Inc. | $24.74 | +15.39% | −42.85% | −63.61% | Nov 5, 2026 |
| LIVN | LivaNova PLC | $79.97 | −2.58% | +31.88% | +41.56% | Nov 4, 2026 |
| OBCK.DE | Ottobock SE & Co. KGaA | 60.40 EUR | +4.50% | +0.68% | +0.68% | Nov 12, 2026 |
| MANE | Veradermics, Incorporated | $102.80 | −7.84% | +172.32% | +172.32% | Nov 12, 2026 |
| TNGX | Tango Therapeutics, Inc. | $25.47 | −4.43% | +185.22% | +269.13% | Nov 4, 2026 |
| RLAY | Relay Therapeutics, Inc. | $19.46 | +6.40% | +137.90% | +445.10% | Nov 5, 2026 |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% | Nov 11, 2026 |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% | Oct 29, 2026 |
| INDV | Indivior Pharmaceuticals, Inc. | $35.83 | −12.60% | +0.27% | +47.06% | Nov 5, 2026 |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% | Nov 4, 2026 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.08 | +89.67% | +224.69% | +292.38% | Nov 5, 2026 |
| IRTC | iRhythm Holdings, Inc. | $119.15 | +1.52% | −32.00% | −29.83% | Nov 5, 2026 |
| 4506.T | Sumitomo Pharma Co., Ltd. | 1,436.50 JPY | +13.47% | −41.63% | −3.59% | Oct 30, 2026 |
| LEGN | Legend Biotech Corporation | $20.68 | +8.61% | −3.86% | −40.44% | Nov 11, 2026 |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% | Nov 9, 2026 |
| VKTX | Viking Therapeutics, Inc. | $34.38 | +1.54% | −2.94% | +29.15% | Oct 28, 2026 |
| DNLI | Denali Therapeutics Inc. | $24.57 | +2.16% | +51.01% | +57.50% | Nov 5, 2026 |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% | Nov 5, 2026 |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% | Oct 27, 2026 |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% | Oct 23, 2026 |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% | Nov 4, 2026 |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% | Nov 5, 2026 |
| FIE.DE | Fielmann Group AG | 39.25 EUR | −5.08% | −10.08% | −27.31% | Aug 27, 2026 |
| 4536.T | Santen Pharmaceutical Co., Ltd. | 1,851.50 JPY | −8.36% | +13.69% | +21.45% | Nov 5, 2026 |
| 7459.T | MediPal Holdings Corporation | 2,893.50 JPY | −5.56% | +4.92% | +13.38% | Nov 5, 2026 |
| IOVA | Iovance Biotherapeutics, Inc. | $8.08 | +71.91% | +220.63% | +233.88% | Nov 5, 2026 |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% | Nov 9, 2026 |
| OPCH | Option Care Health, Inc. | $24.04 | +6.94% | −25.43% | −15.91% | Oct 29, 2026 |
| VCYT | Veracyte, Inc. Common Stock | $44.29 | −20.41% | +4.48% | +54.81% | Nov 3, 2026 |
| GPCR | Structure Therapeutics Inc. | $49.35 | +3.05% | −27.55% | +159.74% | Nov 5, 2026 |
| GRAL | GRAIL, Inc. | $79.59 | +23.55% | −10.44% | +136.66% | Nov 11, 2026 |
| QURE | uniQure N.V. | $50.95 | +38.98% | +117.83% | +223.49% | Nov 9, 2026 |
| NHC | National HealthCare Corporation | $225.09 | −2.56% | +73.28% | +103.83% | Nov 6, 2026 |
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% | Nov 5, 2026 |
| 22Z.DE | Zealand Pharma A/S | 43.35 EUR | +7.70% | −29.74% | −28.16% | Nov 12, 2026 |
| ZEAL.CO | Zealand Pharma A/S | 326.90 DKK | +7.15% | −28.95% | −25.94% | Nov 12, 2026 |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% | Nov 5, 2026 |
| MRVI | Maravai LifeSciences Holdings, Inc. | $8.90 | +29.74% | +161.76% | +281.97% | Nov 5, 2026 |
| NAMS | NewAmsterdam Pharma Company N.V. | $27.40 | −2.07% | −22.16% | +11.97% | Nov 4, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | 6,559.00 JPY | −6.35% | −14.64% | −26.59% | Oct 13, 2026 |
| VIRP.PA | Virbac SA | 329.00 EUR | −5.32% | −6.93% | −2.08% | Sep 17, 2026 |
| MBX | MBX Biosciences, Inc. | $66.76 | +11.16% | +118.53% | +366.53% | Nov 5, 2026 |
| BEAM | Beam Therapeutics Inc. | $30.19 | +14.83% | +11.24% | +79.06% | Nov 3, 2026 |
| TMDX | TransMedics Group, Inc. | $92.22 | +20.88% | −24.83% | −21.43% | Oct 29, 2026 |
| CLDX | Celldex Therapeutics, Inc. | $40.57 | +14.02% | +50.20% | +79.51% | Nov 9, 2026 |
| IRON | Disc Medicine, Inc. | $82.67 | +10.74% | +4.53% | +37.90% | Nov 5, 2026 |
| WRBY | Warby Parker Inc. | $25.48 | −2.00% | +12.64% | −3.96% | Nov 5, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | 2,682.50 JPY | −11.53% | −26.40% | −28.60% | Oct 8, 2026 |
| ARQT | Arcutis Biotherapeutics, Inc. | $25.14 | −11.54% | −13.31% | +60.64% | Oct 27, 2026 |
| TARS | Tarsus Pharmaceuticals, Inc. | $70.65 | +19.85% | −12.53% | +22.19% | Nov 4, 2026 |
| ALMS | Alumis Inc. | $23.62 | −12.62% | +163.76% | +380.08% | Nov 12, 2026 |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% | Nov 4, 2026 |
| HYPE3.SA | Hypera S.A. | 22.01 BRL | +2.66% | −4.58% | −4.69% | Oct 27, 2026 |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% | Nov 5, 2026 |
| BKD | Brookdale Senior Living Inc. | $12.20 | −20.62% | +12.55% | +55.61% | Nov 5, 2026 |
| ALHC | Alignment Healthcare, Inc. | $13.90 | −24.58% | −31.26% | −13.88% | Oct 29, 2026 |
| ACHC | Acadia Healthcare Company, Inc. | $30.58 | −6.45% | +114.00% | +37.81% | Nov 4, 2026 |
| B72.DE | AtaiBeckley Inc. | 6.45 EUR | +2.38% | +88.27% | +59.69% | Nov 12, 2026 |
| SLS | SELLAS Life Sciences Group, Inc. | $13.73 | +36.08% | +215.63% | +615.10% | Nov 11, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% | Oct 8, 2026 |
| 9989.T | Sundrug Co.,Ltd. | 3,715.00 JPY | −6.47% | −11.86% | −17.34% | Nov 13, 2026 |
| VRDN | Viridian Therapeutics, Inc. | $24.26 | +24.35% | −20.93% | +30.71% | Nov 5, 2026 |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% | Nov 12, 2026 |
| RGC | Regencell Bioscience Holdings Limited | $5.50 | −7.87% | −73.22% | −61.38% | Oct 28, 2026 |
| PRVA | Privia Health Group, Inc. | $21.07 | −15.14% | −10.19% | −3.13% | Nov 5, 2026 |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% | Oct 27, 2026 |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% | Oct 28, 2026 |
| VERA | Vera Therapeutics, Inc. | $36.82 | +10.50% | −24.27% | +67.21% | Nov 5, 2026 |
| PGEN | Precigen, Inc. | $7.42 | +34.18% | +73.36% | +61.66% | Nov 12, 2026 |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% | Nov 3, 2026 |
| SUPN | Supernus Pharmaceuticals, Inc. | $44.88 | −5.97% | −9.28% | −0.42% | Nov 3, 2026 |
| RARE | Ultragenyx Pharmaceutical Inc. | $26.44 | +1.77% | +12.03% | −12.10% | Nov 3, 2026 |
| PHVS | Pharvaris N.V. | $37.00 | +9.97% | +39.73% | +55.59% | Nov 12, 2026 |
| BHVN | Biohaven Ltd. | $16.95 | +23.09% | +56.37% | +8.65% | Nov 9, 2026 |
| TRVI | Trevi Therapeutics, Inc. | $17.92 | −2.77% | +50.71% | +124.00% | Nov 12, 2026 |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% | Nov 13, 2026 |
| EMEIS.PA | emeis Société anonyme | 13.80 EUR | −0.86% | −5.61% | +10.93% | Sep 23, 2026 |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% | Oct 8, 2026 |
| 2784.T | Alfresa Holdings Corporation | 2,294.00 JPY | −6.65% | −5.45% | +6.80% | Nov 9, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% | Nov 5, 2026 |
| NKTR | Nektar Therapeutics | $73.77 | +4.24% | +69.90% | +151.95% | Nov 12, 2026 |
| BCRX | BioCryst Pharmaceuticals, Inc. | $9.83 | +0.92% | +31.07% | +15.38% | Nov 2, 2026 |
| CURA.TO | Curaleaf Holdings, Inc. | 13.16 CAD | +8.58% | +267.60% | +197.74% | Nov 4, 2026 |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% | Nov 13, 2026 |
| KOD | Kodiak Sciences Inc. | $39.33 | −2.38% | +51.15% | +321.09% | Nov 12, 2026 |
| PBH | Prestige Consumer Healthcare Inc. | $52.15 | +0.83% | −14.82% | −22.12% | Nov 5, 2026 |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% | Oct 29, 2026 |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% | Oct 27, 2026 |
| NUVB | Nuvation Bio Inc. | $6.96 | +4.04% | −18.88% | +135.93% | Nov 2, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,115.00 JPY | −2.00% | −8.02% | +5.23% | Oct 1, 2026 |
| BHC | Bausch Health Companies Inc. | $6.51 | +44.03% | −9.71% | −10.45% | Oct 28, 2026 |
| BHC.TO | Bausch Health Companies Inc. | 9.03 CAD | +41.09% | −8.97% | −9.88% | Oct 28, 2026 |
| KLRA | Kailera Therapeutics, Inc. | $18.44 | +10.16% | −29.08% | −29.08% | Oct 29, 2026 |
| OCUL | Ocular Therapeutix, Inc. | $10.77 | +27.46% | −8.88% | −12.58% | Nov 4, 2026 |
| ALMR | Alamar Biosciences, Inc. | $34.08 | +37.92% | +54.91% | +54.91% | Nov 5, 2026 |
| GRDN | Guardian Pharmacy Services, Inc. | $37.48 | −10.46% | +26.92% | +45.50% | Nov 9, 2026 |
| UFPT | UFP Technologies, Inc. | $304.57 | +18.02% | +36.33% | +41.94% | Nov 2, 2026 |
| DMP.DE | Dermapharm Holding SE | 42.00 EUR | −1.98% | +8.95% | +27.27% | Nov 12, 2026 |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% | Nov 3, 2026 |
| BFLY | Butterfly Network, Inc. | $8.64 | +20.50% | +130.40% | +450.32% | Oct 30, 2026 |
| COAG | Hemab Therapeutics Holdings, Inc. | $49.19 | +4.08% | +44.68% | +44.68% | Nov 16, 2026 |
| MLYS | Mineralys Therapeutics, Inc. | $25.89 | −3.93% | −27.50% | +70.22% | Nov 10, 2026 |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% | Oct 27, 2026 |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% | Sep 29, 2026 |
| CLOV | Clover Health Investments, Corp. | $4.25 | −1.96% | +76.35% | +57.99% | Nov 4, 2026 |
| MSB.AX | Mesoblast Limited | 2.45 AUD | +19.85% | −11.73% | +1.03% | Aug 27, 2026 |
| ADUS | Addus HomeCare Corporation | $120.71 | +1.25% | +13.26% | +4.50% | Nov 2, 2026 |
| URGN | UroGen Pharma Ltd. | $45.94 | +12.38% | +102.29% | +135.11% | Nov 5, 2026 |
| MESO | Mesoblast Limited | $16.84 | +16.54% | −7.27% | +4.47% | Aug 27, 2026 |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% | Nov 11, 2026 |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.54 | +10.56% | +7.75% | +36.58% | Nov 9, 2026 |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% | Aug 27, 2026 |
| MD | Pediatrix Medical Group, Inc. | $26.95 | +0.34% | +26.59% | +56.87% | Nov 2, 2026 |
| 302440.KS | SK bioscience Co.,Ltd. | 38,100.00 KRW | +17.23% | −20.62% | −20.29% | Oct 26, 2026 |
| XRAY | DENTSPLY SIRONA Inc. | $10.93 | −18.98% | −3.02% | −21.61% | Nov 5, 2026 |
| EXE.TO | Extendicare Inc. | 31.68 CAD | −17.40% | +51.30% | +146.56% | Nov 11, 2026 |
| VCEL | Vericel Corporation | $42.44 | −9.14% | +19.18% | +18.25% | Nov 5, 2026 |
| 9987.T | Suzuken Co., Ltd. | 5,048.00 JPY | −6.26% | −18.11% | −12.93% | Nov 12, 2026 |
| ADMA | ADMA Biologics, Inc. | $9.63 | +9.56% | −46.14% | −44.17% | Nov 4, 2026 |
| ZBIO | Zenas BioPharma, Inc. | $33.04 | +2.32% | −4.23% | +97.73% | Nov 12, 2026 |
| ESTA | Establishment Labs Holdings Inc. | $72.45 | −21.16% | +5.24% | +70.71% | Nov 4, 2026 |
| STOK | Stoke Therapeutics, Inc. | $33.09 | +12.59% | +7.09% | +71.45% | Nov 3, 2026 |
| GN.CO | GN Store Nord A/S | 94.54 DKK | −2.03% | −13.98% | −18.50% | Nov 5, 2026 |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% | Nov 4, 2026 |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% | Nov 5, 2026 |
| NVCR | NovoCure Limited | $17.89 | +9.69% | +36.36% | +50.21% | Oct 29, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% | Sep 10, 2026 |
| GENB | Generate Biomedicines, Inc. | $16.14 | +22.83% | +27.59% | +27.59% | Nov 5, 2026 |
| SRPT | Sarepta Therapeutics, Inc. | $19.46 | +26.12% | −8.68% | +7.69% | Nov 4, 2026 |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% | Sep 29, 2026 |
| PRGO | Perrigo Company plc | $14.76 | +43.30% | +8.65% | −36.05% | Nov 4, 2026 |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $33.99 | −5.56% | +25.06% | −13.45% | Oct 29, 2026 |
| CMPS | COMPASS Pathways plc | $14.61 | +34.65% | +123.05% | +209.53% | Nov 3, 2026 |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,970.00 JPY | +5.37% | +57.28% | +79.12% | Oct 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.